Purpose -This article aims to analyse the reasons for Spanish companies to invest in China and the factors that influence the success or failure of the venture during the implementation process.Design/methodology/approach -This paper is based on an interview held with the two partners of the Garrigues office in Shanghai, Francisco Soler and Manuel Torres. Francisco Soler was responsible for opening and subsequently managing the office from 2005 through to August 2011, when he handed over the reins to Manuel Torres.Findings -The main reason for investing in China is its market. It is worth mentioning here that there has been a paradigm shift whereby China has gone from being the ''world's factory'' to the ''world's market'', not just because of its size but also because of the dizzying speed at which it continues to grow. To minimise the risks of investing in China, the interviewees pointed out the crucial importance of the company committing a significant amount of all kinds of resources to the venture. They also maintain that the investing company should ensure that the people responsible for the project are fully committed to the company and completely familiar with its operations and corporate culture.Originality/value -The value of this study lies in contrasting the practical viewpoint of Garrigues legal consulting firm with the existing literature on the topics discussed in the interview: the reasons why companies invest in China, and the factors that lead to their success or failure.
Background Fibromyalgia (FM) is a musculoskeletal chronic pain condition with low response to pharmacological conventional treatment (CPhT). Multidisciplinary treatment (MT) has showed efficacy in improving FM symptoms. Nevertheless, MT has not been studied in patients with FM and obesity. Objectives To compare the benefits of the CPhT versus the MT (with pharmacological, cognitive-behavioural, and physiotherapy treatments) in a sample of women with FM and obesity (Body Mass Index ≥30). Methods 44 women with obesity and FM according to the American College of Rheumatology criteria. Mean age 49.9 years (S.D. 6.4). 21 patients attended CPhT and 23 MT. Patients were assessed before treatment, after treatment, and at 3-6-12 month follow-up. Outcomes were: pain intensity (Numeric Rating Scale), functionality (FIQ), psychological distress (HADS), quality of life (COOP-WONCA), and sleep problems (Medical Outcome Study: MOS). Results The interaction group x time with mixed linear model analyses demonstrated that patients of the MT group improved more than patients of the CPhT group in pain intensity (p<.001), functionality (p<.0001), quality of life (p<.05), and sleep index problems (p<.001). Conclusions MT consisting of pharmacological treatment, cognitive-behavioural psychological treatment and physiotherapy improves FM symptoms in women with FM and obesity. Improvements were maintained at follow-up. Supported by the Foundation Maratό Grant Number 070910 Disclosure of Interest None Declared
Background Fibromyalgia (FM) is a prevalent musculoskeletal chronic pain condition. Obesity is frequent in patients with FM. Several studies suggests that body mass index (BMI) is related with pain intensity and quality of life. Objectives 1) To determine the prevalence of obesity in a sample of women with FM. 2) To determine the relationship between obesity and the following variables: pain intensity, functionality, psychological distress, quality of life, and sleep problems. Methods 152 women with FM according to the American College of Rheumatology criteria who participated in a multidisciplinary treatment. Patients were assessed before treatment, after treatment, and at 3-6-12 month follow-up. Measures: Body Mass Index (BMI), pain intensity (Numeric Rating Scale), functionality (FIQ), psychological distress (HADS), quality of life (COOP-WONCA), and sleep problems (Medical Outcome Study: MOS). Patients were classified according their BMI: normal weight (BMI <25), overweight (BMI 25.0-29.9), obesity (BMI ≥30). Results The 30.9% (N=47) of the patients were normal weight, the 40.1% (N=61) overweight, and the remaining 28.9% (N=44) obese. Groups were homogeneous regarding to age. ANOVA analysis, with Bonferroni correction, showed no differences between groups in the assessed measures, except in pain intensity. Patients with obesity had more pain than patients with overweight (p<.01). Conclusions 1) As already stated in previous studies, obesity was a frequent comorbid condition in patients with FM. 2) Patients with obesity had more pain than overweight patients. 3) Weight didn’t determine differences in the other studied variables. Supported by the Foundation Maratό Grant Number 070910 Disclosure of Interest None Declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.